Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02801136 · ClinicalTrials.gov registry record · NA
Treatment Outcomes of ReACT for PNES
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT02801136 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 94 participants.
The verdict
NCT02801136, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
This research study is examining the effects of Retraining and Control Therapy (ReACT; an intervention focused on changing behaviors and thoughts) for psychogenic non-epileptic seizures (PNES, episodes resembling epileptic seizures but with no medical explanation). Participants engage in 8 individual therapy sessions consisting of either cognitive behavioral therapy or supportive therapy. Healthy control participants also complete pre-questionnaires and two computer tasks.
Interventions
- BEHAVIORAL ReACT
- BEHAVIORAL Supportive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2016-06 |
| Est. Completion | 2021-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02801136
The ClinicalTrials.gov registry entry for NCT02801136 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ReACT is the first listed.
NCT02801136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02801136 about?
NCT02801136 is a clinical study titled "Treatment Outcomes of ReACT for PNES". This research study is examining the effects of Retraining and Control Therapy (ReACT; an intervention focused on changing behaviors and thoughts) for psychogenic non-epileptic seizures (PNES, episodes resembling epileptic seizures but with no medical explanation). Participants engage in 8 individua...
What is the current status of trial NCT02801136?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2016-06. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02801136?
The interventions under investigation include: ReACT (BEHAVIORAL), Supportive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02801136?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.